Antipsoriatic drugs as inhibitors of soybean lipoxygenase. A possible mode of action

References

1. • Michaelsson G.
   Increased chemotactic activity of neutrophil leukocytes in psoriasis.
   Brit. J. Dermatology. 1980; 103: 351
   • Google Scholar
2. • Malmsten C.L.
   • Palmblad J.
   • Uden A.
   • Radmark O.
   • Engstedt L.
   • Samuelsson B.
   Leukotriene-B₄: A highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes.
   Acts. Physiol. Scand. 1980; 110: 449
   • Google Scholar
3. • Bray M.A.
   • Ford-Hutchinson A.W.
   • Smith M.J.H.
   LeukotrieneB₄: An inflammatory mediator in vivo.
   Prostaglandins. 1981; 22: 213
   • Google Scholar
4. • Bokoch G.M.
   • Reed P.W.
   Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes.
   J. Biol. Chem. 1981; 256: 5317
   • Google Scholar
5. • Bray M.A.
   • Cunningham F.M.
   • Ford-Hutchinson A.W.
   • Smith M.J.H.
   Leukotriene B₄: A mediator of vascular permeability.
   Brit. J. Pharm. 1981; 72: 483
   • Google Scholar
6. • Björk J.
   • Hedqvist P.
   • Arfors K.
   Increase in vascular permeability induced by Leukotriene B4 and the role of polymorphonuclear leukocytes.
   Inflammation. 1982; 6: 189
   • Google Scholar
7. • Goetzl E.J.
   • Woods J.W.
   • Gorman R.R.
   Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.
   J. Clinical Investigation. 1977; 59: 179
   • Google Scholar
8. • Brain S.D.
   • Camp R.D.R.
   • Dowd P.M.
   • Black A.K.
   • Woollard P.M.
   • Mallet A.I.
   • Greaves M.W.
   Psoriasis and Leukotriene B₄.
   Lancet. 1982; 762
   • Google Scholar
9. • Grabbe J.
   • Czarnetzki B.M.
   • Mardin M.
   Chemotactic Leukotrienes in psoriasis.
   Lancet. 1982; 1464
   • Google Scholar
10. • Hammarstrom S.
    • Hamberg M.
    • Samuelsson B.
    • Duell E.A.
    • Stawiski M.
    • Voorhees J.J.
    Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E₂, and prostaglandin F_2α in epidermis of psoriasis.
    in: 5th Ed. Proc. Natl. Acad. Sci., U.S.A.72. 1975: 5130
    • Google Scholar
11. • Hammarstrom S.
    • Lindgren J.A.
    • Marcelo C.
    • Duell E.A.
    • Anderson T.F.
    • Voorhees J.J.
    Arachidonic acid transformations in normal and psoriasic skin.
    J. Investigative Dermatology. 1979; 73: 180
    • Google Scholar
12. • Tappel A.L.
    • Lundberg W.O.
    • Boyer P.D.
    Effect of temperature and antioxidants upon the lipoxidase-catalyzed oxidation of sodium linoleate.
    Arch. Biochem. Biophys. 1953; 42: 293
    • Google Scholar
13. • Sun F.F.
    • McGuire J.C.
    • Morton D.R.
    • Pike J.E.
    • Sprecher H.
    • Kunau W.H.
    Inhibition of platelet arachidonic acid 12-lipoxygenase by acetylenic acid compounds.
    Prostaglandins. 1981; 21: 333
    • Google Scholar
14. • McDonald C.J.
    The uses of systemic chemotherapeutic agents in psoriasis.
    Pharmac. Ther. 1981; 14: 1
    • Google Scholar
15. • Elias P.M.
    • Williams M.L.
    Retenoids, cancer, and the skin.
    Arch. Dermatol. 1981; 117: 160
    • Google Scholar
16. • Bryant B.G.
    Treatment of psoriasis.
    Am. J. Hosp. Pharm. 1980; 37: 814
    • Google Scholar
17. • Hillier K.
    • Castaner J.
    Mycophenolic acid.
    Drugs of the Future. 1978; III: 594
    • Google Scholar
18. • Binazzi M.
    • De Panfilis G.
    • Landi G.
    A controlled multicentric study of RO 10-9359 in association with topical corticosteroid therapy in psoriasis.
    Drugs Exptl. Clin. Res. 1981; VII: 57
    • Google Scholar
19. • Etretinate
    • Tigasan®
    Drugs of the Future. 1981; VI: 187
    • Google Scholar
20. The acid (C₂₁H₂₆O₃; mp 212–216°C) was characterized by elemental analysis, nmr, ir, and uv.
21. • Tappel A.L.
    Lipoxidase.
    in: 5th Ed. Methods in Enzymology. V. Academic Press, New York, London1962: 539
    • Google Scholar
22. • Smith W.L.
    • Lands W.E.M.
    Oxygenation of unsaturated fatty acids by soybean lipoxygenase.
    J. Biol. Chem. 1972; 247: 1038
    • Google Scholar
23. • Gibian M.J.
    • Galaway R.A.
    Steady state kinetics of lipoxygenase oxygenation of unsaturated fatty acids.
    Biochemistry. 1976; 15: 4209
    • Google Scholar
24. • Egmond M.R.
    • Veldink G.A.
    • Vliegenthart J.F.G.
    • Boldingh J.
    C-11 H-abstraction from linoleic acid, the rate limiting step in lipoxygenase catalysis.
    Biochem. Biophys. Res. Commun. 1973; 54: 1178
    • Google Scholar
25. • Russell D.H.
    • Haddox M.K.
    Antiproliferative effects of Retinoids related to the cell cycle-specific inhibition of ornithine decarboxylase.
    in: Modulation of cellular interaction by Vitamin A and Derivatives (Retinoids) Anals of N.Y. Academy of Sciences. 1981: 281 (V-359)
    • Google Scholar
26. • Meyskens Jr., F.L.
    Modulation of abnormal growth by Retinoids: A clinical perspective of the biological phenomenon.
    Life Sciences. 1981; 28: 2323
    • Google Scholar
27. • Voorhees J.J.
    • Orfanos C.E.
    Oral Retinoids: Broad-spectrum dermatologic therapy for the 1980's.
    Arch. Dermatol. 1981; 117: 418
    • Google Scholar
28. • Schaefer H.
    • Schalla W.
    • Shroot B.
    Pharmacology and Kinetics of Anthralin.
    in: Farber E.M. Cox A.J. Psoriasis-Proceedings of Third Int. Symp., Stanford University Grune and Stratton, New York1981: 111
    • Google Scholar
29. • Cashin C.H.
    • Dawson W.
    • Kitchen E.Ann
    The pharmacology of benoxaprofen, (2-[4-Chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis.
    J. Pharm. Pharmacol. 1977; 29: 330
    • Google Scholar
30. • Dawson W.
    • Boot J.R.
    • Harvey J.
    • Walker J.R.
    The pharmacology of benoxaprofen with particular reference to effects on lipoxygenase product formation.
    European J. Rheumatology and Inflammation. 1982; 5: 61
    • Google Scholar
31. • Allen B.R.
    • Littlewood S.M.
    Benoxaprofen: Effect on cutaneous lesions in psoriasis.
    Brit. Med. J. 1982; 285: 1241
    • Google Scholar
32. • Penton D.A.
    • Wilkinson J.D.
    Benoxaprofen: Effect on cutaneous lesions in psoriasis.
    Brit. Med. J. 1982; 285: 1420
    • Google Scholar
33. • Hindson C.
    • Lawlor F.
    • Wacks H.
    Benoxaprofen for nodular acne.
    Lancet. 1982; 1415
    • Google Scholar

34. J.C. Sircar, C.F. Schwender and E.A. Johnson. Soybean Lipoxygenase inhibition by nonsteroidal antiinflammatory drugs. Prostaglandins, in press.

    • Google Scholar
35. • Winthrop G.J.
    Does meclofenamate help psoriasis and arthritis?.
    New England J. Medicine. 1982; 307: 1528
    • Google Scholar
36. • Kinston W.P.
    15-Lipoxygenase: A rapid, sensitive assay for lipoxygenase inhibitors.
    Brit. J. Pharm. 1981; 74: 919P
    • Google Scholar
37. • Harvey J.
    • Parish H.
    • Ho P.P.K.
    • Boot J.R.
    • Dawson W.
    The preferential inhibition of 5-lipoxygenase product formation by benoxaprofen.
    J. Pharm. Pharmacol. 1983; 35: 44
    • Google Scholar